Trial of Vascular Endothelial Growth Factor (VEGF), Bevacizumab, in Combination With Cytotoxic Chemotherapy for Endometrial Cancer

NCT00879359 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Carcinoma

Interventions

DRUG: carboplatin, paclitaxel, and bevacizumab

Sponsor

The Cleveland Clinic

Collaborators

[object Object]